☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
HOOKIPA
HOOKIPA Reports the First Patient Dosing in P-Ib Study of HB-500 to Treat HIV
July 2, 2024
J.P. Morgan Special: Dealmaker 2022 – Top M&A Deal of Roche (Part 01)
January 5, 2023
HOOKIPA and Roche Enter into a License Agreement to Develop HB-700 and Arenaviral Immunotherapies for KRAS-Mutated Cancers
October 21, 2022
HOOKIPA Entered into an Amended and Restated Collaboration and License Agreement with Gilead to Develop Arenaviral Immunotherapies...
February 16, 2022
Load more...
Back to Home